Trial Information

Summary: Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

Eligibility Criteria: Asthmatics on Asthma medications, 18 years and older.
Description: Do you have asthma? The Asthma Research Center at Brigham and Women's Hospital is recruiting asthmatics aged 18 and older who have had asthma for at least 6 months. The research study is 46 weeks long and involves 15 visits to the Asthma Research Center, and the compensation is up to $1970. Study is designed to determine whether adding tiotropium bromide is superior to doubling the dose of an inhaled corticosteroid. All study medication will be provided and are FDA approved. Call us at 617-732-8201 or 1-888-99 ASTHMA or email contact information to arc@partners.org to learn more.

Contact:

Muhammad Zahid, MD, MPH
Asthma Research Center
75 Francis Street, Clinics 1, BP 130
Boston, MA 02115
Telephone: 617-732-8201
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 30, 2008 at 5:03:27 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA